Dr. Paolo Tarantino discusses the importance of strategic sequencing and drug-specific prophylaxis to optimize ADC therapy in breast cancer. The rise of antibody-drug conjugates (ADCs) has transformed ...

Prosigna identified a large high-clinical-risk subgroup with minimal chemotherapy benefit, estimated to avert at most two recurrences per 100 patients treated. Enrollment broadened prior assay use by ...

Dr. Maurie Markman, joins The Moonlight Shift to discuss precision medicine's real-world limits, oncology's cost crisis, ...

OptiTROP-Lung05 randomized 413 untreated, PD-L1 ≥1% advanced NSCLC patients without EGFR/ALK alterations to sac-TMT+pembrolizumab versus pembrolizumab; primary endpoint was PFS. Median PFS was not ...

Updated findings from the phase 3 ROSELLA trial showed that patients with platinum-resistant ovarian cancer continued to experience an overall survival benefit with Lifyorli (relacorilant) plus ...

Progressive disease triggered insomnia and anticipatory grief, highlighting common symptom burden and emotional distress ...

After losing his mother to colorectal cancer in 2009, Michael Sapienza turned unimaginable grief into action. Today, as CEO ...

Here are some of the key gynecologic cancer presentations to watch at ASCO 2026.

A cancer survivor’s wife created a life transition binder during his treatment to organize medical, financial and household information to access details in emergencies. After being diagnosed with ...

First-in-human pancreatic cancer trial at WVU tests an implant that delivers chemotherapy directly into tumors using low-voltage electric pulses. The WVU Cancer Institute is helping lead a global ...

A patient shares motivation after CAR T/TIL therapy as experts reveal caregiver tips for recovery, safety, and avoiding burnout. Timing matters when considering tumor-infiltrating lymphocyte (TIL) ...

Gross hematuria in a younger adult prompted rapid urologic evaluation, underscoring that bladder cancer can present before ...